Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Pharmaceutical Poisoning: Treatment Strategies

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Optical Coherence Tomography Characterization of Coronary Lithotripsy Following Atherectomy for Treatment of Severely Calcified Lesions.

Circulation. Cardiovascular interventions·2026

Same author

Geometric coronary constraints and anatomical feasibility of redo TAVR in Asian patients with Evolut valves: A CT-based simulation study.

Cardiovascular intervention and therapeutics·2026

Same author

Structure and biosynthetic mechanisms of galactomannans in filamentous fungi.

Biochimica et biophysica acta. General subjects·2026

Same author

Dual-Prep registry: Atherectomy devices and intravascUlAr lithotripsy for the PREParation of heavily calcified coronary lesions registry, 1-year results.

Cardiovascular intervention and therapeutics·2026

Same author

Recurrent laryngeal nerve paralysis after prolonged neck dissection under general anesthesia with endotracheal intubation: a case report.

Journal of dental anesthesia and pain medicine·2026

Same author

Heparin-Induced Thrombocytopenia in a Patient With Postoperative Pulmonary Embolism: D-dimer Re-elevation and Progressive Pulmonary Artery Thrombosis.

Cureus·2026

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia

Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia

Published on: July 2, 2013

[Pharmacotherapy for aphasia].

Yutaka Tanaka¹

¹Tanaka Clinic.

Rinsho Shinkeigaku = Clinical Neurology

|January 24, 2008

Summary

This summary is machine-generated.

Pharmacotherapy for aphasia shows promise, with neurotransmitter-stimulating agents potentially improving language function. Dopamine and acetylcholine balance may enhance verbal fluency and naming, particularly in mild to moderate cases.

More Related Videos

Neuronavigation-guided Repetitive Transcranial Magnetic Stimulation for Aphasia

Neuronavigation-guided Repetitive Transcranial Magnetic Stimulation for Aphasia

Published on: May 6, 2016

Related Experiment Videos

Last Updated: Jul 8, 2026

Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia

Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia

Published on: July 2, 2013

Neuronavigation-guided Repetitive Transcranial Magnetic Stimulation for Aphasia

Neuronavigation-guided Repetitive Transcranial Magnetic Stimulation for Aphasia

Published on: May 6, 2016

Area of Science:

Neuroscience
Applied Neurobiology
Pharmacology

Context:

Aphasia classification relies on clinical symptoms, anatomical analysis, or neural networks.
Recent advances in neuroscience and rehabilitation offer new therapeutic avenues based on applied neurobiology.
Pharmacotherapy for aphasia, using neurotransmitter-stimulating agents, has historical roots and ongoing research.

Purpose:

To investigate the potential of pharmacotherapy to improve naming ability in aphasia.
To explore the roles of dopaminergic and cholinergic systems in language function.
To test the hypothesis that a balance between dopaminergic and cholinergic systems is crucial for language.

Summary:

Pharmacotherapy, including dopaminergic, cholinergic, and serotonergic agents, was studied for aphasia treatment.
Improvements were observed in verbal fluency and naming, especially in patients with mild to moderate aphasia.
Observed benefits correlated with reduced perseveration, suggesting neurotransmitter modulation impacts language recovery.

Impact:

Findings suggest a potential role for pharmacotherapy in aphasia rehabilitation.
Highlights the importance of neurotransmitter balance in language processing.
Provides evidence for targeted pharmacological interventions in specific patient populations.